PTHLH and osteoporosis: PTHrP analogs, like abaloparatide, which modifies five residues of PTHrP (1–34) from positions 22 to 34, show a more favorable effect on bone formation with a smaller increase in bone turnover markers compared to teriparatide in osteoporosis clinical studies (Table 1) [29].